Clinical Study
Successful Treatment in Children with Hodgkin Lymphoma in Greece; A 20-Year Experience in a Single Institution
Table 2
Epidemiology and laboratory findings of patients and stage and histology of the disease.
| | | | Stage | | | | Histology*** | | | I | II | III | IV | | MC | LD | LP | NS |
| Gender (boys : girls) | 4 : 3* | 14 : 11 | 10 : 5 | 7 : 4 | ns# | 12 : 1 | 1 : 0 | 4 : 0 | 18 : 22 | Age (years) | 9.8** | 12.1 | 12.3 | 12.9 | ns | 10.2 | 10.2 | 10.5 | 12.5 | WBC (103/mm3) | 7.3 | 11.68 | 9.5 | 10.8 | 0.026 | 7.2 | 4.7 | 7.05 | 11.4 | Neutrophils (%) | 55 | 73.9 | 62 | 78 | 0.001 | 65 | 67 | 54.5 | 72 | Eosinophils (%) | 3.5 | 2 | 3 | 2.7 | ns | 2 | 4 | 3 | 2.6 | Hb (g/dL) | 12.7 | 11 | 10.9 | 10.7 | 0.029 | 11 | 9.2 | 13.8 | 11.1 | PLT (103/mm3) | 342 | 394 | 440 | 385 | ns | 383 | 422 | 301 | 400 | ESR (mm 1st h) | 14 | 63 | 80 | 118 | 0.007 | 66 | 45 | 13 | 70 | CRP (mg/dL) | 20 | 57 | 80 | 110 | ns | 57 | — | 27 | 74 | LDH (mg/dL) | 498 | 319 | 380 | 404 | ns | 324 | — | 446 | 381 |
|
|
*
number of patients, **median values, ***MC: mixed cellularity, LD: lymphocytic depletion, LP: lymphocytic predominance, NS: nodular sclerosis, #non-significant.
|